Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Takeda Pharmaceutical Co. (TAK) had Cash Flow from Investing Activities of $-553.02M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$19.86B |
|
$13.49B |
|
$78.54B |
|
$98.40B |
|
$14.55B |
|
$29.59B |
|
$35.35B |
|
$49.90B |
|
$48.50B |
|
$-10.87B |
|
$48.50B |
|
3.18B |
|
| Cash Flow Statement Financials | |
$4.04B |
|
|
Cash Flow from Investing Activities |
$-553.02M |
$-1.54B |
|
$2.62B |
|
$4.63B |
|
$2.02B |
|
$239.78M |
|
$-1.05B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|